Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2015

  1. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2009

  1. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2195-2196

2008

  1. Severe Hepatitis C Recurrence: Is It a Negative Predictive Factor for Sustained Response to Treatment?

    Gastroenterology

2006

  1. De novo HBV infection caused by an anti-HBc positive donor in a vaccinated liver transplant recipient in spite of anti-HBs response [4]

    American Journal of Transplantation

  2. Hepatitis C Virus Recurrence After Liver Transplantation: Influence of Immunosuppressive Regimens on Viral Load and Liver Histology

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2499-2501

  3. Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose peg-interferon and ribavirin

    American Journal of Transplantation, Vol. 6, Núm. 10, pp. 2348-2355

  4. Improved graft function in liver-transplanted patients after partial splenic embolization: Reversal of splenic artery steal syndrome?

    Clinical Transplantation, Vol. 20, Núm. 4, pp. 517-523

  5. Scarce Influence of Corticosteroid Boluses on Long-Term Viral Load and Liver Histology in Transplanted Patients With Recurrent Hepatitis C

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2502-2504

2005

  1. Accuracy of magnetic resonance cholangiography in the evaluation of late biliary complications after orthotopic liver transplantation

    Transplantation Proceedings

  2. Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: Is there a place for immunomodulatory therapy? [3]

    Gut

  3. HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin

    Journal of Hepatology, Vol. 43, Núm. 5, pp. 783-790

  4. Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?

    American Journal of Transplantation, Vol. 5, Núm. 11, pp. 2796-2798

  5. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin [1]

    Transplantation

  6. Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients

    Transplantation Proceedings

  7. Variability of MELD score during the year before liver transplantation

    Transplantation Proceedings

2004

  1. Controversias en el manejo clínico de la enfermedad de Whipple

    Anales de Medicina Interna, Vol. 21, Núm. 10, pp. 488-490

2003

  1. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: Preliminary results

    Transplantation Proceedings

  2. Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

    Transplantation Proceedings